AudioScholar Psychiatry Weekly

AudioScholar Psychiatry Weekly

AudioScholar
Country USA
Language EN-US
Episodes 10
Latest 16.11.2026

Psychiatry — a weekly podcast briefing of the most significant peer-reviewed psychiatry literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Episodes

  • Dialogical therapy improves recovery in distressing voices
    Dialogical therapy improves recovery in distressing voices 16.11.2026 10m
    Editor's Pick: Dialogical therapy plus treatment as usual versus treatment as usual in adults with distressing and persistent auditory hallucinations in the UK (Talking with Voices-II): a randomised controlled trial (The Lancet Psychiatry, 2026) This AudioScholar briefing is generated by artificial intelligence from PubMed abstracts for healthcare professionals and is not medical advice. This week's papers: 1. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depressive disorder: a systematic review and network meta-analysi…. The Lancet Psychiatry 20...
  • As-needed kudzu cuts AUD binge days, no serious related AEs
    As-needed kudzu cuts AUD binge days, no serious related AEs 09.11.2026 9m
    Editor's Pick: Targeted Use of Kudzu for Binge Drinking Among Adults With Alcohol Use Disorder: A Phase 2b Randomized Trial (American Journal of Psychiatry, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning new evidence in addiction treatment and service delivery, biological signatures of aging and treatment response across depression, trauma and catatonia, and the d… This week's papers: 1. Targeted Use of Kudzu for...
  • Single intranasal mebufotenin dose eases TRD for 8 weeks
    Single intranasal mebufotenin dose eases TRD for 8 weeks 02.11.2026 10m
    Editor's Pick: Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial (JAMA, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning new approaches to depression and acute trauma, the long arc of schizophrenia treatment, and a set of sobering negative and reframing findings in suicide preventio… This week's papers: 1. Single Intranasal Administration...
  • GLP-1 RAs in schizophrenia tied to lower HbA1c and lipids
    GLP-1 RAs in schizophrenia tied to lower HbA1c and lipids 26.10.2026 10m
    Editor's Pick: Metabolic biomarker levels before and after initiation of GLP-1 receptor agonist treatment among individuals with schizophrenia: interrupted time-series analysis (British Journal of Psychiatry, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning prediction and subtyping in depression, metabolic care and circuit biology in schizophrenia, and the experiences of families after psychiatric assisted dying. Th...
  • rTMS tied to ~4x response odds vs drugs in late-life TRD
    rTMS tied to ~4x response odds vs drugs in late-life TRD 19.10.2026 11m
    Editor's Pick: Effectiveness of rTMS vs. Pharmacotherapy in Late-Life Treatment-Resistant Depression: An Observational Study of Individual Participant Data From Two Randomized Clinical Trials (American Journal of Psychiatry, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning treatment options for depression, the metabolic side of severe mental illness, suicide risk and compulsory care, and adult ADHD. Let's dive in. T...
  • ADHD in older adults tied to 4x risk of MCI or dementia
    ADHD in older adults tied to 4x risk of MCI or dementia 12.10.2026 11m
    Editor's Pick: Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment (JAMA Psychiatry, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning suicide risk and psychological treatment in young people, the uneven road to precision psychiatry, and neurodevelopmental conditions across the lifespan. This week's papers: 1. Trajectories of suicidal ideation and attempts across the academic year: longitudina...
  • Antipsychotic efficacy doesn't differ by sex; prolactin does
    Antipsychotic efficacy doesn't differ by sex; prolactin does 05.10.2026 11m
    Editor's Pick: Sex differences in the efficacy, acceptability, and tolerability of antipsychotics in people with acute schizophrenia: individual participant data pairwise, dose-response, and network meta-analyses (The Lancet Psychiatry, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning psychotropic safety and who benefits from our medications, the rapidly expanding field of brain stimulation and its biomarkers, and n...
  • Escitalopram, amitriptyline prolong QT most, no MACE rise
    Escitalopram, amitriptyline prolong QT most, no MACE rise 28.09.2026 12m
    Editor's Pick: QTc changes and early major adverse cardiovascular events associated with antidepressant treatment for major depressive disorder in adults: individual participant data network meta-regression of double blind randomised trials (BMJ, 2026) This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice. Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning prescribing safety and comparative efficacy, familial and developmental risk across psychosis, substance use and depression...
  • CAMHS contact preceded 58% of psychotic, bipolar diagnoses
    CAMHS contact preceded 58% of psychotic, bipolar diagnoses 21.09.2026 11m
    Editor's Pick: Psychotic and bipolar disorder diagnoses following contact with child and adolescent mental health services-a longitudinal, nationwide register study of 2 million individuals (Journal of Child Psychology and Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning early identification of serious mental illness, family- and child-focused interventions, and the reward circuitry that underlies depression and eating disorders,… This week's papers: 1. Psychotic and bipolar disorder diagnoses following contact with child and adolescent...
  • Mood stabiliser tied to fewer admissions than SGA alone
    Mood stabiliser tied to fewer admissions than SGA alone 14.09.2026 11m
    Editor's Pick: Comparative effectiveness of mood stabiliser monotherapy versus second-generation antipsychotic monotherapy versus combination therapy for continuation and maintenance treatment after a first episode of psychotic mania in North America, Chile, and Spain: a target trial emulation using data from the BD-CAUSAL Collaboration (The Lancet Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning severe mental illness treatment selection, personalised and pharmacogenomic prescribing, and the shifting landscape of child and adolescent dia...
  • Ketamine lowers bipolar depression, no manic switches
    Ketamine lowers bipolar depression, no manic switches 07.09.2026 10m
    Editor's Pick: Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial (JAMA Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning treatment-resistant mood disorders and neuromodulation, addiction and behavioural neuroscience, and the developmental and social determinants that shape who gets… This week's papers: 1. Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial.. JAMA Psychiatry 2026. 2. Nutraceuticals and phytoceuticals for the treatment of major dep...
  • GLP-1 RAs in SMI linked to ~25% lower mortality vs SGLT2
    GLP-1 RAs in SMI linked to ~25% lower mortality vs SGLT2 31.08.2026 11m
    Editor's Pick: Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness (JAMA Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning service models and treatment-resistant illness, the physical health and monitoring burden carried by people with severe mental illness, and trauma, measurement an… This week's papers: 1. Open Dialogue versus treatment as usual for adults presenting in crisis to mental health services in England (the ODDESSI Trial): a multisite cluster-randomise…. The Lancet Psych...
  • Cannabis use disorder up 2021–2024; alcohol severity stable
    Cannabis use disorder up 2021–2024; alcohol severity stable 24.08.2026 11m
    Editor's Pick: Trends in the Prevalence and Severity of Alcohol and Cannabis Use Disorders Among US Adults (JAMA Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning substance use and psychosis risk, treatment personalisation across depression, eating disorders and schizophrenia, and the widening world of neurodevelopmental ca… This week's papers: 1. A Systematic Review of Long-term Safety Outcomes of Ketamine and Esketamine in Patients with Treatment-resistant Depression. Psychotherapy and Psychosomatics 2026. 2. Cannabis Use and Age-Relate...
  • Bipolar treatments vary by phase and age, fewer for youth
    Bipolar treatments vary by phase and age, fewer for youth 17.08.2026 13m
    Editor's Pick: Evidence based interventions for bipolar disorder across phases and age groups: living umbrella review, evaluation, analysis, and communication hub (U-REACH) project (BMJ, 2026) Welcome to This Week in Psychiatry. This week we're covering 10 notable papers spanning precision treatment in mood disorders, the risks and realities of antidepressant use and discontinuation, the physical health gap in severe mental illness, and ne… This week's papers: 1. Evidence based interventions for bipolar disorder across phases and age groups: living umbrella review, evaluation, analysis, and co...
  • Task-shared therapy: social support tied to most benefit
    Task-shared therapy: social support tied to most benefit 10.08.2026 8m
    Editor's Pick: Optimising and personalising task-shared psychosocial interventions for common mental disorders: a Bayesian component network meta-analysis of individual participant data (The Lancet Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we're covering seven notable papers spanning psychedelic and trauma-focused psychotherapy trials, the hard problem of scaling and prevention when interventions are simplified or delivered universally, and… This week's papers: 1. Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting:...
  • This Week in Psychiatry — Aug 3, 2026
    This Week in Psychiatry — Aug 3, 2026 03.08.2026 8m
    Editor's Pick: Association between maintenance doses of mood stabilizers and antipsychotics and risk of readmission in first-episode bipolar disorder (Molecular Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we are covering eight notable papers spanning the neurobiological subtypes of psychiatric disorders, the critical intersections of genetics, development, and environment in youth, and the long-term clinic… This week's papers: 1. Association between maintenance doses of mood stabilizers and antipsychotics and risk of readmission in first-episode bipolar disorder.. Molecular...
  • This Week in Psychiatry — Jul 31, 2026
    This Week in Psychiatry — Jul 31, 2026 31.07.2026 15m
    Editor's Pick: Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial (The American Journal of Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we are covering ten notable papers spanning three major clinical themes. First, we will examine novel pharmacotherapeutic approaches and their neurobiological mechanisms, focusing on oral semaglutide for… This week's papers: 1. Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial. The American Journal of Psychiatry 2026. 2. Escitalopram and brain reactivity to aggressive stimuli in premenstrual dysphoric...
  • This Week in Psychiatry — Jul 20, 2026
    This Week in Psychiatry — Jul 20, 2026 20.07.2026 13m
    Editor's Pick: Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study (The Lancet Psychiatry, 2026) Welcome to This Week in Psychiatry. This week we are covering ten notable papers spanning three broad themes: novel therapeutic targets and interventions in addiction, the optimization of pharmacotherapy and real-world prescribing patterns in mood di… This week's papers: 1. Association of GLP-1 receptor agonists with a...
  • This Week in Psychiatry — Jul 13, 2026
    This Week in Psychiatry — Jul 13, 2026 13.07.2026 14m
    Editor's Pick: Mega-analysis of Structural Brain Imaging in Functional Neurological Disorder (Biological psychiatry, 2026) Welcome to This Week in Psychiatry. This week we are covering ten notable papers spanning three broad themes: the neurobiological subtyping of psychiatric disorders, the developmental and behavioral determinants of mental health, and the future of cl… This week's papers: 1. Association between childhood neglect and psychiatric disorders in adults: systematic review, meta-analysis and meta-regression.. The British journal of psychiatry : the journal of mental science 2026....
  • This Week in Psychiatry — Jul 6, 2026
    This Week in Psychiatry — Jul 6, 2026 06.07.2026 11m
    Editor's Pick: Venous thromboembolism after mechanical restraint in psychiatric hospitals: population based cohort and self-controlled case series study (BMJ (Clinical research ed.), 2026) Welcome to This Week in Psychiatry. This week we're covering 5 notable papers spanning two broad themes: first, how genetic predispositions, environmental stressors, and peer networks dynamically interact to shape psychiatric risk from childhood thro… This week's papers: 1. Venous thromboembolism after mechanical restraint in psychiatric hospitals: population based cohort and self-controlled case series stud...

Popular in

The podcast also appears in the podcast charts of these countries.